Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Post-stroke depression: diagnosis and therapy].

W Huff1, S Ruhrmann, M Sitzer

  • 1Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klinikum der Universität zu Köln. Wolfgang.Huff@t-online.de

Fortschritte Der Neurologie-Psychiatrie
|December 26, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MicroRNA 29 modulates β-cell mitochondrial metabolism and insulin secretion via underlying miR-29-OXPHOS complex pathways.

Acta physiologica (Oxford, England)·2024
Same author

Associations between disturbed sleep and attenuated psychotic experiences in people at clinical high risk for psychosis.

Psychological medicine·2024
Same author

Effect of childhood physical abuse on social anxiety is mediated via reduced frontal lobe and amygdala-hippocampus complex volume in adult clinical high-risk subjects.

Schizophrenia research·2020
Same author

Development of a stage-dependent prognostic model to predict psychosis in ultra-high-risk patients seeking treatment for co-morbid psychiatric disorders.

Psychological medicine·2016
Same author

EPA guidance on the early intervention in clinical high risk states of psychoses.

European psychiatry : the journal of the Association of European Psychiatrists·2015
Same author

EPA guidance on the early detection of clinical high risk states of psychoses.

European psychiatry : the journal of the Association of European Psychiatrists·2015

Poststroke depression (PSD) affects up to 40% of stroke survivors, often going undiagnosed and untreated. Early intervention, particularly with SSRIs, shows promise for improving functional outcomes in these patients.

Area of Science:

  • Neurology
  • Psychiatry
  • Clinical Medicine

Context:

  • Poststroke depression (PSD) affects 30-40% of stroke survivors.
  • Standardized diagnostic criteria for PSD are lacking.
  • PSD is frequently underdiagnosed and untreated despite its high prevalence.

Purpose:

  • To review the prevalence, diagnosis, and treatment of poststroke depression.
  • To highlight the impact of PSD on functional recovery after stroke.
  • To discuss potential therapeutic interventions for PSD.

Summary:

  • PSD is common after stroke, impacting functional outcomes.
  • Current diagnostic approaches rely on general psychiatric criteria or rating scales.
  • Selective Serotonin Reuptake Inhibitors (SSRIs) show favorable outcomes in limited studies.

Related Experiment Videos

Impact:

  • Untreated PSD leads to poorer functional recovery and long-term disability.
  • Early and appropriate treatment of PSD is crucial for optimizing patient outcomes.
  • Further research is needed to establish optimal timing, type, and intensity of PSD interventions.